Vesicular neurotransmitter transporters: From bacteria to humans

Physiological Reviews

Volumn 75, Issue 2, 1995, Pages 369-392

  Schuldiner, Shimon ^a   Shirvan, Anat ^a   Linial, Michal ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMINO ACID; GLUTAMIC ACID; GLYCOPROTEIN P; MONOAMINE; NEUROTRANSMITTER; RESERPINE;

ACTIVE TRANSPORT; AMINO ACID TRANSPORT; CELL MEMBRANE TRANSPORT; DRUG RESISTANCE; ENZYME SPECIFICITY; HUMAN; INTRACELLULAR TRANSPORT; MONOAMINE RELEASE; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; SYNAPSE VESICLE; TRANSPORT KINETICS;

EID: 0028912433     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.1995.75.2.369     Document Type: Review

References (172)

1. AHMED, M., C. BORSCH, A, NEYFAKH, AND S. SCHULDINER. Mutants of the Bacillus subtilis multidrug transporter bmr with altered sensitivity to the antihypertensive alkaloid reserpine. J. Biol. Chem. 268: 11086-11089, 1993.
2. ALFONSO, A., K. GRUNDAHL, J. S. DUERR, H. P. HAN, AND J. B. RAND. The Caenorhabditis elegans Unc-17 gene - a putative vesicular acetylcholine transporter. Science Wash. DC 261: 617-619, 1993.
3. AMARA, S. Neurotransmitter transporters - a tale of 2 families. Nature Lond. 360: 420-421, 1992.
4. AMARA, S. G., AND M. J. KUHAR. Neurotransmitter transporters - recent progress. Annu. Rev. Neurosci. 16: 73-93, 1993.
5. 3H]acetylcholine by Torpedo electric organ synaptic vesicles. Biochemistry 21: 3037-3043, 1982.
6. BAHR, B., E. CLARKSON, G. ROGERS, K. NOREMBERG, AND S. PARSONS. A kinetic and allosteric model for the acetylcholine transporter-vesamicol receptor in synaptic vesicles. Biochemistry 31: 5752-5762, 1992.
7. BAHR, B., K. NOREMBERG, G. ROGERS, B. HICKS, AND S. PARSONS. Linkage of the acetylcholine transporter-vesamicol receptor to proteoglycan in synaptic vesicles. Biochemistry 31: 5778-5784, 1992.
8. BAHR, B., AND S. PARSONS. Acetylcholine transport and drug inhibition kinetics in Torpedo synaptic vesicles. J. Neurochem. 46: 1214-1218, 1986.
9. 3H]piperidino)cyclohexanol. Proc. Natl. Acad. Sci. USA 83: 2267-2270, 1986.
10. BAHR, B., AND S. PARSONS. Purification of the vesamicol receptor. Biochemistry 31: 5763-5769, 1992.
11. BAJJALIEH, S., K. PETERSON, M. LINIAL, AND R. SCHELLER. Brain contains two forms of synaptic vesicle protein 2. Proc. Natl. Acad. Sci. USA 90: 2150-2154, 1993.
12. BAJJALIEH, S., K. PETERSON, R. SHINGHAL, AND R. SCHELLER. SV2, a brain synaptic vesicle protein homologous to bacterial transporters. Science Wash. DC 257: 1271-1273, 1992.
13. BIBI, E., G. VERNER, C. Y. CHANG, AND H. KABACK. Organization and stability of a polytopic membrane protein: deletion analysis of the lactose permease of Escherichia coli. Proc. Natl. Acad. Sci. USA 88: 7271-7275, 1991.
14. BINDRA, P., R. KNOWLES, AND K. BUCKLEY. Conservation of the amino acid sequence of SV2, a transmembrane transporter in synaptic vesicles and endocrine cells. Gene 137: 299-302, 1993.
15. BRENNER, S. The genetics of C. elegans. Genetics 77: 71-94, 1974.
16. BUCKLEY, K., AND R. KELLY. Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. J. Cell Biol. 100: 1284-1294, 1985.
17. BURGER, P., J. HELL, E. MEHL, C. KRASEL, F. LOTTSPEICH, AND R. JAHN. GABA and glycine in synaptic vesicles - storage and transport characteristics. Neuron 7: 287-293, 1991.
18. BURGER, P. M., E. MEHL, P. L. CAMERON, P. R. MAYCOX, M. BAUMERT, F. LOTTSPEICH, P. DE CAMILLI, AND R. JAHN. Synaptic vesicles immunoisolated from rat cerebral cortex contain high levels of glutamate. Neuron 3: 715-20, 1989.
19. CARLSON, M. D., P. E. KISH, AND T. UEDA. Characterization of the solubilized and reconstituted ATP-dependent vesicular glutamate uptake system. J. Biol. Chem. 264: 7369-7376, 1989.
20. CARLSON, M. D., P. E. KISH, AND T. UEDA. Glutamate uptake into synaptic vesicles: competitive inhibition by bromocriptine. J. Neurochem. 53: 1889-1894, 1989.
21. CARLSSON, A. Drugs which block the storage of 5-hydroxytryptamine and related amines. Handb. Exp. Pharmacol. 19: 529-592, 1965.
22. CARMICHAEL, S., A. WEBER, AND H. WINKLER. Uptake of nucleotides and catecholamines by chromaffin granules from pig and horse adrenal medulla. J. Neurochem. 35: 270-272, 1980.
23. CASEY, R., D. NJUS, G. RADDA, AND P. SEHR. Adenosine triphosphate evoked catecholamine release in chromaffin granules. Osmotic lysis as a consequence of proton translocation. Biochem. J. 158: 583-588, 1976.
24. CHAPLIN, L., A. H. COHEN, P. HUETTL, M. KENNEDY, D. NJUS, AND S. TEMERLEY. Reserpic acid as an inhibitor of norepinephrine transport into chromaffin vesicle ghosts. J. Biol. Chem. 260: 10981-10985, 1985.
25. CLARKSON, E., G. ROGERS, AND S. PARSONS. Binding and active transport of large analogues of acetylcholine by cholinergic synaptic vesicles in viro. J. Neurochem. 59: 695-700, 1992.
26. DANBOLT, N., G. PINES, AND B. KANNER. Purification and reconstitution of the sodium-coupled and potassium-coupled glutamate transport glycoprotein from rat brain. Biochemistry 29: 6734-6740, 1990.
27. DANIELS, A. J., AND J. F. REINHARD. Energy driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the cathecholamine transporter. J. Biol. Chem. 263: 5034-36, 1988.
28. DARCHEN, F., D. SCHERMAN, C. DESNOS, AND J.-P. HENRY. Characteristics of the transport of the quaternary ammonium 1-methyl-4-phenylpyridinium by chromaffin granules. Biochem. Pharmacol. 37: 4381-4387, 1988.
29. DARCHEN, F., D. SCHERMAN, AND J. HENRY. Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter. Biochemistry 28: 1692-1697, 1989.
30. DEISENHOFER, J., O. EPP, K. MIKI, R. HUBER, AND H. MICHEL. Structure of the protein subunits in the photosynthetic reaction centre of Rhodopseudomonas viridis at 3A resolution. Nature Land. 318: 618-624, 1985.
31. DEISENHOFER, J., AND H. MICHEL. The photosynthetic reaction (center from the purple bacterium Rhodopseudomonas viridis. Science Wash. DC 245: 1463-1473, 1989.
32. DESNOS, C., M. LARAN, AND D. SCHERMAN. Regulation of the chromaffin granule catecholamine transporter in cultured bovine adrenal medullary cells - stimulus biosynthesis coupling. J. Neurochem. 59: 2105-2112, 1992.
33. DESNOS, C., B. RAYNAUD, S. VIDAL, M. WEBER, AND D. SCHERMAN. Induction of the vesicular monoamine transporter by elevated potassium concentration in cultures of rat sympathetic neurons. Dev. Brain Res. 52: 161-166, 1990.
34. 3H]glumatic acid by crude and purified synaptic vesicles from rat brain. Biochem. Biophys. Res. Commun. 108: 1221-1227, 1982.
35. ENDICOTT, J., AND V. LING. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58: 137-171, 1989.
36. ERICKSON, J., AND L. EIDEN. Functional identification and molecular cloning of a human brain vesicle monoamine transporter. J. Neurochem. 61: 2314-2317, 1993.
37. ERICKSON, J., L. EIDEN, AND B. HUFFMAN. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc. Natl. Acad. Sci. USA 89: 10993-10997, 1992.
38. ERICKSON, J. D., H. VAROQUI, M. K. H. SCHAFER, W. MODI, M. F. DIEBLER, E. WEIHE, J. RAND, L. EIDEN, T. I. BONNER, AND T. B. USDIN. Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J. Biol. Chem. 269: 21929-21932, 1994.
39. FEANY, M., S. LEE, R. EDWARDS, AND K. BUCKLEY. The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell 70: 861-867, 1992.
40. FELSENSTEIN, J. Phylogenies from molecular sequences: inference and reliability. Annu. Rev. Genet. 22: 521-565, 1988.
41. FLOWERS, T., P. TROKE, AND A. YEO. The mechanism of salt tolerance in halophytes. Annu. Rev. Plant Physiol. 28: 89-121, 1977.
42. FRIZE, E. Mental depression in hypertensive patients treated for long periods with high doses of reserpine. N. Engl. J. Med. 251: 1006-1008, 1954.
43. FYKSE, E., AND F. FONNUM. Uptake of GABA by a synaptic vesicle fraction isolated from rat brain. J. Neurochem. 50: 1237-1242, 1988.
44. 2+. Biochem. J. 276: 363-367, 1991.
45. FYKSE, E. M., H. CHRISTENSEN, AND F. FONNUM. Comparison of the properties of γ-aminobutyric acid and L-glutamate uptake into synaptic vesicles isolated from rat brain. J. Neurochem. 52: 946-951, 1989.
46. GASNIER, B., M. ROISIN, D. SCHERMAN, S. COORNAERT, G. DESPLANCHES, AND J. HENRY. Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes. Mol. Pharmacol. 29: 275-280, 1986.
47. GASNIER, B., D. SCHERMAN, AND J. HENRY. Dicyclohexylcarbodiimide inhibits the monoamine carrier of bovine chromaffin granule membrane. Biochemistry 24: 1239-1244, 1985.
48. GINGRICH, J., P. ANDERSON, M. TIBERI, S. MESTIKAWY, P. JORGENSEN, R. FREMEAU, AND M. CARON. Identification, characterization and molecular cloning of a novel transporter-like protein localized to the central nervous system. FEBS Lett. 312: 115-122, 1992.
49. + ATPase in proximal and distal urinary acidification. J. Bioenerg. Biomembr. 24: 351-359, 1992.
50. +-ATPase: implications for the origin of eukaryotes. Proc, Natl. Acad. Sci. USA 86: 6661-6665, 1989.
51. GRIFFITH, J., M. BAKER, D. ROUCH, M. PAGE, R. SKURRAY, I. PAULSEN, K. CHATER, S. BALDWIN, AND P. HENDERSON. Evolution of transmembrane transport: relationships between transport proteins for sugars, carboxylate compounds, antibiotics and antiseptics. Curr. Opin. Cell Biol. 4: 684-695, 1992.
52. GROS, P., F. TALBOT, D. TANGWAI, E. BIBI, AND H. KABACK. Lipophilic cations - a group of model substrates for the multidrug-resistance transporter. Biochemistry 31: 1992-1998, 1992.
53. GUASTELLA, J., N. NELSON, H. NELSON, L. CZYZYK, S. KEYNAN, M. C. MIEDEL, N. DAVIDSON, A. H. LESTER, AND B. I. KANNER. Cloning and expression of a rat brain GABA transporter. Science Wash. DC 249: 1303-1306, 1990.
54. HAMA, H., AND T. WILSON. Cation-coupling in chimeric melibiose carriers derived from E. coli and Klebsiella pneumonia. J. Biol. Chem. 268: 10060-10065, 1993.
55. HARTINGER, J., AND R. JAHN. An anion binding site that regulates the glutamate transporter of synaptic vesicles. J. Biol. Chem. 268: 23122-23127, 1993.
56. HELL, J. W., P. R. MAYCOX, AND R. JAHN. Energy dependence and functional reconstitution of the γ-aminobutyric acid carrier from synaptic vesicles. J. Biol. Chem. 265: 2111-2117, 1990.
57. HELL, J. W., P. R. MAYCOX, H. STADLER, AND R. JAHN. Uptake of GABA by rat brain synaptic vesicles isolated by a new procedure. EMBO J. 7: 3023-3029, 1988.
58. HENRY, J., AND D. SCHERMAN. Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles. Biochem. Pharmacol. 38: 2395-2404, 1989.
59. HIGGINS, C., AND M. GOTTESMAN. Is the multidrug transporter a flippase? Trends Biochem. Sci. 17: 18-21, 1992.
60. HOWELL, M., A. SHIRVAN, Y. STERN-BACH, S. STEINER-MORDOCH, J. STRASSER, G. DEAN, AND S. SCHULDINER. Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules. FEBS Lett. 338: 16-22, 1994.
61. ISAMBERT, M., B. GASNIER, D. BOTTON, AND J. HENRY. Characterization and purification of the monoamine transporter of bovine chromaffin granules. Biochemistry 31: 1980-1986, 1992.
62. ISAMBERT, M., AND J. HENRY. Effect of diethylpyrocarbonate on pH-driven monoamine uptake by chromaffin granule ghosts. FEBS Lett. 136: 13-18, 1981.
63. JOHNSON, R. Accumulation of biological amines in chromaffin granules: a model for hormone and neurotransmitter transport. Physiol. Rev. 68: 232-307, 1988.
64. KABACK, H. The lactose permease of Escherichia coli: a paradigm for membrane transport proteins. Biochim. Biophys. Acta 1101: 210-213, 1992.
65. KANAI, Y., AND M. HEDIGER. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature Lond. 360: 467-471, 1992.
66. KANNER, B. Glutamate transporters from brain - a novel neurotransmitter transporter family. FEBS Lett. 325: 95-99, 1993.
67. KANNER, B. I., AND A. BENDAHAN. Binding order of substrates to the sodium and potassium ion coupled L-glutamic acid transporter from rat brain. Biochemistry 21: 6327-6330, 1982.
68. KANNER, B. I., AND S. SCHULDINER. Mechanism of transport and storage of neurotransmitters. CRC Crit. Rev. Biochem. 22: 1-38, 1987.
69. KAUFMAN, R., G. A. ROGERS, C. FEHLMANN, AND S. M. PARSONS. Fractional vesamicol receptor occupancy and acetylcholine active transport inhibition in synaptic vesicles. Mol. Pharmacol. 36: 452-456, 1989.
70. KIRSHNER, N. Uptake of catecholamines by a particulate fraction of the adrenal medulla. J. Biol. Chem. 237: 2311-2317, 1962.
71. KISH, P., AND T. UEDA. Glutamate accumulation into synaptic vesicles. Methods Enzymol. 174: 9-25, 1989.
72. KISH, P. E., C. FISCHER-BOVENKERK, AND T. UEDA. Active transport of γ-aminobutyric acid and glycine into synaptic vesicles. Proc. Natl. Acad. Sci. USA 86: 3877-3891, 1989.
73. KOBOLD, G., R. LANGER, AND A. BURGER. Does the carrier of chromaffin granules transport the protonated or the uncharged species of catecholamines? Naunyn-Schmiedebergs Arch. Pharmacol. 331: 209-219, 1985.
74. KREJCI, E., B. GASNIER, M. BOTTON, M. ISAMBERT, C. SAGNE, J. GAGNON, J. MASSOULIE, AND J. HENRY. Expression and regulation of the bovine vesicular monoamine transporter gene. FEBS Lett. 335: 27-32, 1993.
75. 2+ by isolated secretory vesicles from adrenal medulla. Biochim. Biophys. Acta 691: 61-70, 1982.
76. 2+ fluxes across chromaffin secretory membrane vesicles. J. Neurochem. 41: 1269-1276, 1983.
77. LINIAL, M. Vesicular transporters join the major facilitator superfamily (MFS). Trends Biochem. Sci. 18: 248-249, 1993.
78. + toxicity encodes a vesicular amine transporter. Cell 70: 539-551, 1992.
79. LIU, Y., A. ROGHANI, AND R. EDWARDS. Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium. Proc. Natl. Acad. Sci. USA 89: 9074-9078, 1992.
80. LUQMANI, Y. A. Nucleotide uptake by isolated cholinergic synaptic vesicles: evdience for a carrier of adenosine 5′-triphosphate. Neuroscience 6: 1011-1021, 1981.
81. MARGE, M., AND M. SAIER. A major superfamily of transmembrane facilitators catalyzing uniport, symport and antiport. Trends Biochem. Sci. 18: 13-20, 1993.
82. MARON, R., H. FISHKES, B. KANNER, AND S. SCHULDINER. Solubilization and reconstitution of the catecholamine transporter from bovine chromaffin granules. Biochemistry 18: 4781-4785, 1979.
83. MARON, R., Y. STERN, B. I. KANNER, AND S. SCHULDINER. Functional asymmetry of the amine transporter from chromaffin granules. J. Biol. Chem. 258: 11476-11481, 1983.
84. MARSHALL, I. Studies on the blocking action of 2-(4-phenyl piperidino)cyclohexanol (AH5183). Br. J. Pharmacol. 38: 503-516, 1970.
85. MARSHALL, I., AND S. PARSONS. The vesicular acetylcholine transport system. Trends Neurosci. 10: 174-177, 1987.
86. MATSUMURA, M., D. FREMONT, P. PETERSON, AND I. WILSON. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science Wash. DC 257: 927-934, 1992.
87. MAYCOX, P., T. DECKWERTH, AND R. JAHN. Bacteriorhodopsin drives the glutamate transporter of synaptic vesicles after co-reconstitution. EMBO J. 9: 1465-1469, 1990.
88. MAYCOX, P. R., T. DECKWERTH, J. W. HELL, AND R. JAHN. Glutamate uptake by brain synaptic vesicles. J. Biol. Chem. 263: 15423-15428, 1988.
89. MAYCOX, P. R., J. W. HELL, AND R. JAHN. Amino acid neurotransmission: spotlight on synaptic vesicles. Trends Neurosci. 13: 83-87, 1990.
90. MITCHELL, P. Chemiosmotic Coupling and Energy Transduction. Bodmin, Cornwall, UK: Glynn Research, 1968.
91. MORIYAMA, Y., K. AMAKATSU, H. YAMADA, M. PARK, AND M. FUTAI. Inhibition of neurotransmitter and hormone transport into secretory vesicles by 2-4-phenylpiperidinocyclohexanol and 2-bromo-alpha-ergocryptine: both compounds act as uncouplers and dissipate the electrochemical gradient of protons. Arch. Biochem. Biophys. 290: 233-238, 1991.
92. 1) and its reconstitution into liposomes with neurotransmitter transporters. J. Biol. Chem. 266: 22141-22146, 1991.
93. NAITO, S., AND T. UEDA. Adenosine triphosphate-dependent uptake of glutamate into protein I-associated synaptic vesicles. J. Biol. Chem. 258: 696-699, 1983.
94. NAITO, S., AND T. UEDA. Characterization of glutamate uptake into synaptic vesicles. J. Neurochem. 44: 99-109, 1985.
95. NELSON, N. Structural conservation and functional diversity of V-ATPases. J. Bioenerg. Biomembr. 24: 407-414, 1992.
96. NELSON, P., AND G. RUDNICK. Coupling between platelet 5-hydroxytryptamine and potassium transport. J. Biol. Chem. 254: 10084-10089, 1979.
97. NELSON, P., AND G. RUDNICK. The role of chloride ion in platelet serotonin transport. J. Biol. Chem. 57: 6151-6155, 1982.
98. NEYFAKH, A. The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Antimicrob. Agents Chemother. 36: 484-485, 1992.
99. NEYFAKH, A., V. BIDNENKO, AND L. CHEN. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian MDR. Proc. Natl. Acad. Sci. USA 88: 4781-4785, 1991.
100. NICHOLLS, D., AND S. FERGUSON. Bioenergetics 2. London: Academic, 1992.
101. NIKAIDO, H. Prevention of drug access to bacterial targets: permeability barrier and active efflux. Science Wash. DC 264: 382-388, 1994.
102. NJUS, D., P. M. KELLEY, AND G. J. HARNADEK. Bioenergetics of secretory vesicles. Biochim. Biophys. Acta 853: 237-265, 1986.
103. NJUS, D., J. KNOTH, AND M. ZALLAKIAN. Proton-linked transport in chromaffin granules. Curr. Top. Bioenerg. 11: 107-147, 1981.
104. +-ATPase activity. J. Biol Chem. 266: 13971-13977, 1991.
105. PADAN, E., H. K. SARKAR, P. V. VITANEN, M. S. POONIAN, AND H. R. KABACK. Site-specific mutagenesis of histidine residues in the lac permease of Escherichia coli. Proc. Natl. Acad. Sci. USA 82: 6765-6768, 1985.
106. PARSONS, S., B. BAHR, G. ROGERS, E. CLARKSON, K. NOREMBERG, AND B. HICKS. Acetylcholine transporter-vesamicol receptor pharmacology and structure. Prog. Brain Res. 98: 175-181, 1993.
107. PARSONS, S. M., B. A. BAHR, G. A. ROGERS, E. D. CLARKSON, K. NOREMBERG, AND B. W. HICKS. Acetylcholine transporter vesamicol receptor pharmacology and structure. In: Cholinergic Function and Dysfunction, edited by A. C. Cuello. Amsterdam: Elsevier, 1993, chapt. 20, p. 175-181.
108. PARTI, R., E. D. OZKAN, G. J. HARNADEK, AND D. NJUS. Inhibition of norepinephrine transport and reserpine binding by reserpine derivatives. J. Neurochem. 48: 949-953, 1987.
109. PAULSEN, I., AND R. SKURRAY. Topology, structure and evolution of two families of proteins involved in antibiotic and antiseptic resistance in eukaryotes and prokaryotes - an analysis. Gene 124: 1-11, 1993.
110. PETER, D., J. FINN, I. KLISAK, Y. LIU, T. KOJIS, C. HEINZMANN, A. ROGHANI, R. SPARKES, AND R. EDWARDS. Chromosomal localization of the human vesicular amine transporter genes. Genomics 18: 720-723, 1993.
111. PETER, D., J. JIMENEZ, Y. LIU, J. KIM, AND R. EDWARDS. The chromaffin granule and synaptic vesicle transporters differ in substrate recognition and sensitivity to inhibitors. J. Biol. Chem. 269: 7231-7237, 1994.
112. + across the chromaffin-granule membrane. Biochem. J. 200: 99-107, 1981.
113. PINES, G., N. DANBOLT, M. BJORAS, Y. ZHANG, A. BENDAHAN, L. EIDE, H. KOEPSELL, J. STORMMATHISEN, E. SEEBERG, AND B. KANNER. Cloning and expression of a rat brain L-glutamate transporter. Nature Lond. 360: 464-467, 1992.
114. PLETSCHER, A. Effect of neuroleptics and other drugs on monoamine uptake by membrane of adrenal chromaffin granules. Br. J. Pharmacol. 59: 419-424, 1977.
115. PRASAD, P. D., F. H. LEIBACH, V. MAHESH, AND V. GANAPATHY. Specific interaction of 5-(N-methyl-N-isobutyl)amiloride with the organic cation-proton antiporter in human placental brush-border membrane vesicles. J. Biol. Chem. 267: 23632-23629, 1992.
116. RAMU, A., M. LEVINE, AND H. POLLARD. Chemical evidence that catecholamines are transported across the chromaffin granule membrane as noncationic species. Proc. Natl. Acad. Sci. USA 80: 2107-2111, 1983.
117. RAND, J. Genetic analysis of the cha1-unc17 gene complex in Caenorhabditis. Genetics 122: 73-80, 1989.
118. REINHARD, J. F., JR., E. J. DILIBERTO, JR., AND A. J. DANIELS. Characterization of cellular transport, subcellular distribution, and secretion of the neurotoxicant 1-methyl-4-phenylpyridinium in bovine adrenomedullary cell cultures. J. Neurochem. 52: 1253-1257, 1989.
119. ROGERS, G., AND S. PARSONS. Inhibition of acetylcholine storage by acetylcholine analogs in vitro. Mol. Pharmacol. 36: 333-341, 1989.
120. ROGERS, G., AND S. PARSONS. Photoaffinity labeling of the acetylcholine transporter. Biochemistry 31: 5770-5777, 1992.
121. ROGERS, G., S. PARSONS, D. ANDERSON, L. NILSSON, B. BAHR, W. KORNREICH, R. KAUFMAN, R. JACOBS, AND B. KIRTMAN. Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol). J. Med. Chem. 32: 1217-1230, 1989.
122. ROGERS, G. A., AND S. M. PARSONS. Photoaffinity labeling of the vesamicol receptor of cholinergic synaptic vesicles. Biochemistry 32: 8596-8601, 1993.
123. ROGHANI, A., J. FELDMAN, S. A. KOHAN, A. SHIRZADI, C. B. GUNDERSEN, N. BRECHA, AND R. H. EDWARDS. Molecular cloning of a putative vesicular transporter for acetylcholine. Proc. Natl. Acad. Sci. USA 91: 10620-10624, 1994.
124. ROTTENBERG, H. Energetics of proton transport and secondary transport. Methods Enzymol. 125: 3-15, 1986.
125. RUDNICK, G., AND J. CLARK. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim. Biophys. Acta 1144: 249-263, 1993.
126. RUDNICK, G., K. L. KIRK, H. FISHKES, AND S. SCHULDINER. Zwitterionic and anionic forms of a serotonin analog as transport substrates. J. Biol. Chem. 264: 14865-14868, 1989.
127. RUDNICK, G., S. S. STEINER-MORDOCH, H. FISHKES, Y. STERN-BACH, AND S. SCHULDINER. Energetics of reserpine binding and occlusion by the chromaffin granule transporter. Biochemistry 29: 603-608, 1990.
128. RUDNICK, G., AND S. WALL. Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters. Mol. Pharmacol. 43: 271-276, 1993.
129. RUDNICK, G., AND S. C. WALL. The molecular mechanism of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. USA 89: 1817-1821, 1992.
130. RUDNICK, G., AND S. C. WALL. p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry 31: 6710-6718, 1992.
131. SCHERMAN, D. Dihydrotetrabenazine binding and monoamine uptake in mouse brain regions. J. Neurochem. 47: 331-339, 1986.
132. SCHERMAN, D., AND G. BOSCHI. Time required for transmitter accumulation inside monoaminergic storage vesicles differs in peripheral and in central systems. Neuroscience 27: 1029-1035, 1988.
133. SCHERMAN, D., AND J.-P. HENRY. pH dependence of the ATP-dependent uptake of noradrenaline by bovine chromaffin granule ghosts. Eur. J. Biochem. 116: 535-539, 1981.
134. SCHERMAN, D., AND J.-P. HENRY. Reserpine binding to bovine chromaffin granule membranes. Mol. Pharmacol. 25: 113-22, 1984.
135. 3H]dihydrotetrabenazine. Proc. Natl. Acad. Sci. USA 80: 584-588, 1983.
136. SCHERTLER, G. F. X., H. D. BARTUNIK, H. MICHEL, AND D. OESTERHELT. Orthorhombic crystal form of Bacteriorhodopsin nucleated on benzamidine diffracting to 3 center dot 6 angstrom resolution. J. Mol. Biol. 234: 156-164, 1993.
137. SCHULDINER, S. A molecular glimpse of vesicular monoamine transporters. J. Neurochem. 62: 2067-2078, 1994.
138. SCHULDINER, S., H. FISHKES, AND B. I. KANNER. Role of a transmembrane pH gradient in epinephrine transport by chromaffin granule membrane vesicles. Proc. Natl. Acad. Sci. USA 75: 3713-3716, 1978.
139. SCHULDINER, S., Y. LIU, AND R. EDWARDS. Reserpine binding to a vesicular amine transporter expressed in Chinese hamster ovary fibroblasts. J. Biol. Chem. 268: 29-34, 1993.
140. + antiporters in bacterial cell physiology. Int. Rev. Cytol. 137: 229-266, 1993.
141. SCHULDINER, S., S. STEINER-MORDOCH, R. YELIN, S. C. WALL, AND G. RUDNICK Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. Mol. Pharmacol. 44: 1227-1231, 1993.
142. SCRANTON, T. W., M. IWATA, AND S. S. CARLSON. The SV2 protein of synaptic vesicles is a keratan sulfate proteoglycan. J. Neurochem. 60: 29-44, 1993.
143. SHIOI, J., S. NAITO, AND T. UEDA. Glutamate uptake into synaptic vesicles of bovine cerebral cortex and electrochemical potential difference of proton across the membrane. Biochem. J. 258: 499-504, 1989.
144. SHIOI, J., AND T. UEDA. Artificially imposed electrical potentials drive L-glutamate uptake into synaptic vesicles of bovine cerebral cortex. Biochem. J. 267: 63-68, 1990.
145. SOKOL, P., AND T. McKINNEY. Mechanism of organic cation transport in rabbit renal basolateral membrane vesicles. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F1599-F1607, 1990.
146. STERN-BACH, Y., N. GREENBERG-OFRATH, I. FLECHNER, AND S. SCHULDINER. Identification and purification of a functional amine transporter from bovine chromaffin granules. J. Biol. Chem. 265: 3961-3966, 1990.
147. STERN-BACH, Y., J. KEEN, M. BEJERANO, S. STEINER-MORDOCH, M. WALLACH, J. FINDLAY, AND S. SCHULDINER. Homology of a vesicular amine transporter to a gene conferring resistance to 1-methyl-4-phenylpyridinium. Proc. Natl. Acad. Sci. USA 89: 9730-9733, 1992.
148. STIETZEN, M., M. SCHOBER, R. FISCHER-COLBRIE, D. SCHERMAN, G. SPERK, AND H. WINKLER. Rat adrenal medulla: levels of chromogranins, enkephalins, dopamine β-hydroxylase and of the amine transporter are changed by nervous activity and by hypophysectomy. Neuroscience 22: 131-139, 1987.
149. STITZEL, R. E. The biological fate of reserpine. Pharmacol. Rev. 28: 179-205, 1977.
150. +-dependent glutamate aspartate transporter from rat brain. Proc. Natl. Acad. Sci. USA 89: 10955-10959, 1992.
151. SUCHI, R., Y. STERN-BACH, T. GABAY, AND S. SCHULDINER. Covalent modification of the amine transporter with N,N′ -dicyclohexylcarbodiimide. Biochemistry 30: 6490-6494, 1991.
152. SUCHI, R., Y. STERN-BACH, AND S. SCHULDINER. Modification of arginyl or histidyl groups affects the energy coupling of the amine transporter. Biochemistry 31: 12500-12503, 1992.
153. SULZER, D., N. MAIDMENT, AND S. RAYPORT. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60: 527-535, 1993.
154. SULZER, D., AND S. RAYPORT. Amphetamine and other psychostimulants reduce pH gradient in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5: 797-808, 1990.
155. SURRATT, C., A. PERSICO, X. YANG, S. EDGAR, G. BIRD, A. HAWKINS, C. GRIFFIN, X. LI, E. JABS, AND G. UHL. A human synaptic vesicle monoamine transporter cDNA predicts posttranslational modifications, reveals chromosome 10 gene localization, and identifies Taq1 RFLPS. FEBS Lett. 318: 325-330, 1993.
156. SUSSMAN, J., M. HAREL, F. FROLOW, C. OEFNER, A. GOLDMAN, L. TOKER, AND I. SILMAN. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine binding protein. Science Wash. DC 253: 872-879, 1991.
157. TABB, J., P. KISH, R. VANDYKE, AND T. UEDA. Glutamate transport into synaptic vesicles - roles of membrane potential, pH gradient, and intravesicular pH. J. Biol. Chem. 267: 15412-15418, 1992.
158. THOMASREETZ, A., J. W. HELL, M. J. DURING, C. WALCHSOLIMENA, R. JAHN, AND P. DECAMILLI. A γ-aminobutyric acid transporter driven by a proton pump is present in synaptic-like microvesicles of pancreatic beta-cells. Proc. Natl. Acad. Sci. USA 90: 5317-5321, 1993.
159. TOLL, L., AND B. D. HOWARD. Evidence that an ATPase and a proton-motive force function in the transport of acetylcholine into storage vesicles. J. Biol. Chem. 255: 1787-1789, 1980.
160. VANDENBERGH, D., A. PERSICO, AND G. UHL. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic Taqi RFLPs. Mol. Brain Res. 15: 161-166, 1992.
161. VAROQUI, H., M. DIEBLER, F. MEUNIER, J. RAND, T. USDIN, T. BONNER, L. EIDEN, AND J. ERICKSON. Cloning and expression of the vesamicol binding protein from the marine ray Torpedo: homology with the putative vesicular acetylcholine transporter unc17 from Caenorhabditis elegans. FEBS Lett. 342: 97-102, 1994.
162. 3H]dihydrotetrabenazine-binding protein from bovine adrenal medulla. Mol. Pharmacol. 40: 889-894, 1991.
163. WEAVER, J. A., AND J. D. DEUPREE. Conditions required for reserpine binding to the catecholamine transporter on chromaffin granule ghosts. Eur. J. Pharmacol. 80: 437-438, 1982.
164. WEBER, A., E. W. WESTHEAD, AND H. WINKLER. Specificity and properties of the nucleotide carrier in chromaffin granules from bovine adrenal medulla. Biochem. J. 210: 789-794, 1983.
165. WEBER, A., AND H. WINKLER. Specificity and mechanism of nucleotide uptake by adrenal chromaffin granules. Neuroscience 6: 2269-2276, 1981.
166. WHITTAKER, V. Cholinergic synaptic vesicles from the electromotor nerve terminals of Torpedo. Ann. NY Acad. Sci. 493: 77-91, 1987.
167. WINK, M. The plant vacuole: a multifunctional compartment. J. Exp. Bot. 44: 231-246, 1993.
168. WINTER, H., AND T. UEDA. Glutamate uptake system in the presynaptic vesicle: glutamic acid analogs as inhibitors and alternate substrates. Neurochem. Res. 18: 79-85, 1993.
169. + antiporter of Escherichia coli. Biochemistry 32: 5698-5704, 1993.
170. + antiporter of Escherichia coli encoded by transposon Tn10: the structural resemblance and functional difference in the role of the duplicated sequence motif between hydrophobic segment-2 and segment-3 and segment-8 and segment-9. J. Biol. Chem. 268: 6496-6504, 1993.
171. + antiporter of Escherichia coli. J. Biol. Chem. 268: 26990-26995, 1993.
172. ZILBERSTEIN, D., J. WILKES, H. HIRUMI, AND A. PEREGRINE. Fluorescence analysis of the interaction of isometamidium with Trypanosoma congolense. Biochem. J. 292: 31-35, 1993.